Brief: Atomo Diagnostics Says Receives Approval For Its Covid-19 Antigen Test In NZ
27/01/2022 04:40
Jan 27 (Reuters) - Atomo Diagnostics Ltd AT1.AX :
* ATOMO RECEIVES APPROVAL FOR ITS COVID-19 ANTIGEN TEST IN
NZ
Source text for Eikon: ID:nASX3t78FS
Further company coverage: AT1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atomo Diagnostics
See all newsBrief: Atomo Diagnostics Signs Agreement With Innovation Scientific
Brief: Atomo Diagnostics Ltd Appoints Cheri Walker As Interim Ceo
Brief: Atomo Diagnostics Undertakes Capital Raising To Raise Up To A$4.0 Million
Australia's Atomo Diagnostics slumps on discounted capital raising
Brief: Atomo Diagnostics Seeks Trading Halt